Fresenius Medical Expects Smaller Annual Income Decline Amid Easing Cost Inflation, Labor Shortages
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q2 sales reached $3.88 billion, up 2% Y/Y (4% on constant currency), slightly beating the
Earnings Scheduled For August 2, 2023
Companies Reporting Before The Bell
• Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
Fresenius Medical Care: Q1 Earnings Insights
Fresenius Medical Care (NYSE:FMS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure
Fresenius Medical Care AG & Co (NYSE:FMS) has implemented its new operating model with two global segments: Care Enablement (Health Care…
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Fresenius Medical Care Expects FY23 Revenue To Grow At A Low To Mid-Single-Digit Percentage Rate
Operating income is expected to remain flat or decline by up to a high-single-digit percentage rate in 2023.
By 2025 Fresenius Medical Care targets to achieve an improved operating income margin of 10 to 14%.
Fresenius Medical Care Q4 Adjusted EPS €0.86 Down From €0.90 YoY, Sales €5.00B Up From €4.65B YoY
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of €0.86 per share. This is a 4.44 percent decrease over earnings of €0.90 per share from the same period last year. The company reported €5.00
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.
